The Biological Window in Alzheimer’s Disease: Real-World Lab Data for Commercial Execution
For real-world data (RWD) and commercial teams navigating the complex landscape of early-stage...
.png)
Precision Targeting in Rare Disease: Why Lab Data is the "Early Warning System" Pharma Needs
We are living in an era of unprecedented rare disease advocacy. Medical parents and patient groups...
The Data Quality Illusion: Why Aggregated EHR Feeds Often Fail
In the life sciences industry, "lab data" is often treated as a commodity. The assumption is that a...
Beyond the Centers of Excellence: Maximizing ROI and Finding the Missing Rare Disease Patient Cohort
The pursuit of patients with rare diseases is a critical but notoriously challenging endeavor for...
Rare Disease Pharma: Navigating the DOJ's Sponsored Testing Ruling
The Department of Justice (DOJ) recently made waves in the pharmaceutical industry with a ruling...
The Challenges of Genomics Data for Rare Disease Patients
Niyati Parikh, Vice President, Clinical Solutions